WEBCAST  Broadcast October 21, 2021

We hope you were able to attend the live event. If you were not able to join on the day you can watch OnDemand.

The webcast is now available to watch with an option of French and German subtitles.

WATCH OnDEMAND

Programme Director Professor Martin Savage is joined by experts to present and discuss the application of precision medicine in endocrine disorders, offering clinical expertise and insight, evidence and opinion on this topic.

This programme is suitable for global endocrinologists, paediatricians, nurses, and any other healthcare professional involved in management of endocrine disorders.

Session Speaker
Welcome and introduction Martin Savage
Precision medicine in accurate biochemical diagnosis Martin Bidlingmaier
Q&A ALL
Value of genetic analyses in precision medicine Ana Claudia Latronico
Q&A ALL
Achieving precision medicine through transitional care Helena Gleeson
Q&A and close ALL

Emeritus Professor of Paediatric Endocrinology

William Harvey Research Institute, Barts and the London School of Medicine & Dentistry, London, UK

Martin Savage is Emeritus Professor of Paediatric Endocrinology at William Harvey Research Institute, Barts and the London School of Medicine & Dentistry in London. He was head of the Paediatric Endocrine Unit at Barts and the London School of Medicine from 1982 to 2007. He is a clinician with clinical and research interests in growth disorders, specifically those with abnormalities in the growth hormone-IGF-1 axis. His main research field has been the phenotype:genotype relationships of GH-IGF-1 axis defects. He published the first human case of an IGF-1 gene defect in the New England Journal of Medicine in 1996.

His other clinical interests are Cushing’s syndrome and growth in chronic inflammatory diseases. He was General Secretary of the European Society for Paediatric Endocrinology (ESPE) from 1997 to 2004. Professor Savage has lectured in 59 countries world-wide and has published over 440 original articles, reviews, textbook chapters and books. In 2007, he was awarded the ESPE Andrea Prader Prize for contributions to paediatric endocrinology and in 2018 he received a Visionary Award from the American Human Growth Foundation. He continues to lecture nationally and internationally.

View full disclosure information

Consultant Endocrinologist

Queen Elizabeth Hospital, Birmingham, UK

Helena Gleeson is a consultant endocrinologist at Queen Elizabeth Hospital Birmingham. Her research into the late effects of cancer therapy at Christie Hospital Manchester highlighted the importance of seamless care for patients with childhood conditions that have health implications in adulthood. She works in the late effects service in Birmingham and is involved in writing guidelines on endocrine late effects for the Society for Endocrinology. Dr Gleeson is also involved in national initiatives to improve adolescent health care and transition, with a focus on training of healthcare professionals.

View full disclosure information

Professor of Medicine

University of São Paolo, Brazil

Ana Claudia Latronico is a full professor of medicine at Sao Paulo Medical School, Head of the Endocrinology and Metabology Service at Hospital das Clínicas; Vice-Coordinator of the Post-Graduate Program in Endocrinology, Principal Researcher at the Laboratory of Hormones and Molecular Genetics at Sao Paulo University in Sao Paulo, Brazil. Dr Latronico earned her doctorate in Endocrinology at Sao Paulo University and National Institutes of Health (Maryland, USA). She is full member of the Brazilian Academy of Sciences.

Dr Latronico has been honoured with several awards, including Richard E. Weitzman Memorial Award (2003) and International Excellence Award (2019) granted by the Endocrine Society. Author of more than 190 original manuscripts published in international and national journals, including four publications in The New England Journal of Medicine. Her current work focuses on clinical and molecular aspects of precocious puberty, hypogonadotropic hypogonadism and adrenocortical tumours.

View full disclosure information

Head of Endocrinology and Metabology Service

Ludwig-Maximilians University, Germany

Martin Bidlingmaier is an MD and graduated from medical school in Munich, Germany, in 1993. Since then he has risen through the ranks at Munich University hospitals and got training in Internal Medicine, Endocrinology, Clinical Chemistry and Microbiology. Since 2003 Dr. Bidlingmaier is head of the Endocrine Laboratories and leads the Neuroendocrine Research Group at the Department of Internal Medicine.

His research interests include development and validation of laboratory methods for pituitary and adrenal hormones, clinical applications and biochemical monitoring of growth hormone (GH), physiology and pathophysiology of GH and its isoforms and endocrine aspects of doping in sports.

Dr Bidlingmaier is a member of various national and international associations such as the German, the European and the US Endocrine Society. In 2014 he was appointed secretary of the Growth Hormone Research Society (GRS), He also chairs the Sections for Endocrine Laboratory Diagnostics of the German Endocrine Society (DGE) and the German Society for Clinical Chemistry and Laboratory Medicine (DGKL) and is scientific advisor of the German Reference Institute for Bioanalytics (RfB). Between 2011 and 2019, he served as a member of the World Anti-doping Agencies (WADA) Prohibited List Expert Group. He is also a member of the German National Anti-Doping Agencies (NADA) Commission for the Doping Control System.

Dr. Bidlingmaier is author of more than 300 articles in peer-reviewed journals (h-index 55), and serves on the editorial board of several journals.

View full disclosure information

After participating in the webcast you will be able to:

  1.  Explain how precision medicine can contribute to accurate biochemical diagnosis of endocrine disorders
  2.  Utilize genetic analyses appropriately to enable personalized clinical management of endocrine disorders
  3.  Integrate precision medicine practices and tools into transitional care for endocrine disorders

Accreditation applies to live event only

The Precision medicine in endocrine disorders: how can we ensure application from diagnosis through transitional care?, London, United Kingdom, 21/10/2021-21/10/2021 has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 1 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.

Through an agreement between the Union Européenne des Médecins Spécialistes and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 Credits™. Information on the process to convert EACCME® credit to AMA credit can be found at www.ama-assn.org/education/earn-credit-participation-international-activities.

Live educational activities, occurring outside of Canada, recognised by the UEMS-EACCME® for ECMEC®s are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.

This programme is made possible thanks to an educational grant received from: Merck Healthcare KGaA, Darmstadt, Germany.